This will be the first time the option has been taken up since it was introduced at the beginning of 2025, under the Medical Research Act.

Novo Nordisk A/S is suffering from headwinds in its core anti-obesity medications market. Click here to find out why NVO ...

Despite current headwinds like tariffs and patent expirations, I see long-term opportunity in top-tier pharmaceutical stocks ...

Did you analyze how Eli Lilly (LLY) fared in its international operations for the quarter ending June 2025? Given the widespread global presence of this drugmaker, scrutinizing the trends in ...

Eli Lilly (LLY) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...

Eli Lilly and Company (NYSE: LLY) is one of the top most profitable NYSE stocks to buy now. On August 7, Leerink downgraded ...

Eli Lilly and Company (NYSE: LLY) is one of the Good Stocks to Invest in Now. On August 7, Eli Lilly and Company (NYSE:LLY) ...

An updated guideline on pharmacotherapy of obesity management in adults includes six new and seven revised recommendations, ...

Here are five oral obesity candidates that, according to Mizuho’s Graig Suvannavejh, could change the weight loss game.

A legacy ranch in Jackson Hole, WY, has come onto the market, with records showing it is owned by former Eli Lilly exec Dr. Jan Lundberg.

William “Bill” Joseph Cruser, 80, of Greenwood, IN passed away Tuesday, August 5, 2025, at Community Hospital South in ...

Now, Eli Lilly says its experimental GLP-1 pill is a success after the first phase-three trial. The company said more than 3,000 adults on the experimental oral medication lowered their weight by an ...